CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Daniil, Zoe ^a   Kitsanta, Panagiota ^b   Kapotsis, George ^a   Mathioudaki, Maria ^b   Kollintza, Androniki ^a   Karatza, Marilena ^b   Milic Emili, Joseph ^c   Roussos, Charis ^a   Papiris, Spyros A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ELASTASE; MONOCLONAL ANTIBODY; OXYGEN;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BREATHING MECHANICS; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPNEA; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMAGE ANALYSIS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LABELING INDEX; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG INJURY; LUNG PARENCHYMA; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONONUCLEAR CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PNEUMONIA; PROGNOSIS; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; T LYMPHOCYTE; TOTAL LUNG CAPACITY; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX;

CD8-POSITIVE T-LYMPHOCYTES; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX;

EID: 26244439518     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-81     Document Type: Article

References (51)

1. Katzenstein A, Zisman AD, Litzky AL, Nguyen TB, Kotloff MR: Usual interstitial pneumonia. Histologic study of biopsy and explant specimens. Am J Surg Pathol 2002, 26:1567-1577.
2. Flaherty KR, Travis WD, Colby TV, Toews BG, Kazerooni AE, Gross HB, Jain A, Strawderman LR III, Flint A, Lynch PJ III, Martinez JF: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164:1722-1727.
3. Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 2001, 345:517-525.
4. Riches WHD, Worthen GS, Augustin A, Lapadat R, Chan DE: Inflammation in the pathogenesis of interstitial lung disease. In Interstitial Lung Disease Edited by: Schwartz JM, King ET Jr. Hamilton London BC Decker; 2003:187-220.
5. Kradin RL, Divertie MB, Colvin RB, Ramirez J, Ryu J, Carpenter HA, Bhan AK: Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopathol 1986, 40:224-235.
6. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976, 85:769-788.
7. Hunninghake GW, Kawanami O, Ferrans VJ, Young RC, Roberts WC, Crystal RG: Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients interstitial lung disease. Am Rev Respir Dis 1981, 123:407-412.
8. Campell DA, Poulter LW, Janossy G, du Bois RM: Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 1985, 40:405-411.
9. Haslam PL, Turton CW, Lukoszek A, Salsbury AJ, Dewar A, Collins JV, Turner-Warwick M: Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980, 35:328-339.
10. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberst WC, Frank MM, Crystal RG: Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977, 59:165-175.
11. Peterson MW, Monick M, Hunninghake GW: Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987, 92:51-56.
12. Lynch JP 3rd, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992, 145:1433-1439.
13. Selman M, King TE Jr, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications therapy. Ann Intern Med 2001, 134:136-151.
14. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassali P: Tumor necrosis factor/cachectin plays a key role in bleomycin induced pneumopathy and fibrosis. J Exp Med 1989, 170:655-663.
15. 8+ T-lymphocytes. J Leukocyte Biol 1993, 54:414-422.
16. Furuie H, Yamasaki H, Suga M, Ando M: Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th 2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J 1997, 10:787-794.
17. Hancock A, Armstrong L, Gama R, Millar A: Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998, 18:60-65.
18. Romagnani S: Th1/Th2 cells. Inflamm Bowel Dis 1999, 5:285-294.
19. American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000, 161:646-664.
20. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C: Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. Eur Respir J 1993:5-40.
21. Cotes JE, Chinn DJ, Quanjer PhH, Roca J, Yernault J-C: Standardization of the measurement of transfer factor (Diffusing Capacity). Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. Eur Respir J 1993:41-52.
22. Eltayara L, Becklake MR, Volta CA, Milic-Emili J: Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154:1726-1734.
23. Brugal T, Arnorssen R, Bengtsson A, Wilander E: A double scanning micromorphometer for image analysis: hardware, software and biomedical applications. J Histochem Cytochem 1979, 27:144-152.
24. Charpin C, Martin P, Jacquemin J, Jacquemier J, Lavaut MN, Pourreau-Schneider N, Toga M: Estrogen receptor immunocytochemical assay (ER-ICA): Computerized image analysis system, immunoelectron microscopy and comparisons with estradiol binding assays in 115 breast assays in 115 breast carcinomas. Cancer Res 1986:4271-4277.
25. Costes V, Marty-Ane C, Picot MC, Serre I, Pujol J-L, Mary H, Baldet P: Typical and Atypical Bronchopulmonary Carcinoid Tumors: A Clinicopathologic and Ki-67-Labeling Study. Hum Pathol 1995, 26:740-745.
26. White SR, Lazar HM, Thannichal JV: Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 2003, 201:343-354.
27. Haslam LP, Turton WGC, Heard B, Lukoszek A, Collins VJ, Slasbury A, Turner-Warwick: Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980, 35:9-18.
28. Haslam LP: Evaluation of alveolitis by studies of lung biopsies. Lung 1990:984-992.
29. Paradis LI, Dauber HJ, Rabin SB: Lymphocyte phenotypes in bronchoalveolar lavage and lung biopsies in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986, 13:855-860.
30. Yamadori I, Fujiata J, Kajitani H, Tokuda M, Yang Y, Ohtsuki Y, Yoshinouchi T, Kamei T, Ishida T: Lymphocytic subsets in lung tisuue of non-specific interstitial pneumonia and pulmonary fibrosis associated with collagen vascular disorders: correlation with CD4/CD8 ratio in bronchoalveolar lavage. Lung 2000, 178:361-370.
31. Fulmer JD, Roberts WC, Von Gal R, Crystal RG: Morphologicphysiologic correlates of the severity of fibrosis and degree of cellular infiltration in idiopathic pulmonary fibrosis. J Clin Invest 1979, 63:665-676.
32. Green GM, Graham GB, Hanson JS, Gump DW, Phillips CA, Brody AR, Sylvester DW, Landis JN, Davis GS, Craighead JE: Correlate studies of interstitial pulmonary disease. Chest 1976:263.
33. Gaensler EA, Carrington CB, Coutu RE, FitzGerald MX: Radiologicphysiologic-pathologic correlations in interstitial pneumonias. Prog Respir Res 1975, 8:223-241.
34. Gaensler EA, Carrington CB: Open lung biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiologic correlations in 502 patients. Ann Thorac Surg 1980, 30:411-426.
35. Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon JG: Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990, 45:675-768.
36. Groen H, Hamstra M, Aalbert R, Van Der Mark WT, Koëter HG, Postma SD: Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis. Respir Med 1994, 88:55-64.
37. Fireman E, Vardinon N, Burke M, Soizer S, Levin S, Endler A, Stav D, Topilsky M, Mann A, Schwarz S, Greif J: Predictive value of response to treatment of T-lymhocyte subpopulations in idiopathic pulmonary fibrosis. Eur Respir J 1998, 11:706-711.
38. Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, Konig G, Fruhmann G: Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 1996, 154:400-6.
39. Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, Alms WJ, White B: Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999, 42:1168-78.
40. Luzina IG, Atamas SP, Wise R, Wigley FM, Choi J, Xiao HQ, White B: Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum 2003, 48:2262-74.
41. Papiris SA, Vlachoyiannopoulos PG, Maniati MA, Karakostas KX, Constantopoulos SH, Moutsopoulos HH: Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses. Respiration 1997, 64:81-5.
42. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch JP 3rd, Martinez FJ: Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003, 167:1410-5.
43. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM: A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999, 160:899-905.
44. Ramsay A, Ruby J, Ramshaw I: A case for cytokine as effector molecules in the resolution of virus infection. Immunol Today 1993, 14:155-157.
45. Alwan WH, Kozlowska WJ, Opensaw PJ: Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994, 179:81-89.
46. Guidotti LG, Chisari FV: To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996, 8:478-483.
47. + T Lymphocytes in experimental lung disease. J Clin Invest 1998, 102:1653-1661.
48. + T Cell-mediated Injury In Vivo Progresses in the Absence of Effector T Cells. J Exp Med 2001, 194:1835-1846.
49. Croft M, Carter L, Swain SL, Dutton RWL: Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994, 180:1715-1728.
50. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA: Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002, 99:6292-6297.
51. Strieter RM, Keane MP: Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J Clin Invest 2004, 114:165-168.